Stocks to Watch: Sonosite, Novellus, FedEx (Update 2)
NEW YORK (TheStreet) -- Fujifilm Holdings of Japan said Thursday it reached a deal to acquire Sonosite (SONO), a maker of ultrasound and cardiograph equipment, for about $995 million.
Fujifilm will make an all-cash tender offer to buy the outstanding shares of SonoSite for $54 a share in cash.
Sonosite shares were soaring 26.7% to $53.50 in premarket trading Thursday.
Lam Research (LRCX) agreed to acquire Novellus Systems (NVLS) for $3.3 billion in stock. The deal values Novellus at $44.42 a share, a premium of nearly 30% to Wednesday's close at $34.70. The merger of Lam and Novellus is the fourth biggest semiconductor tie-up in 2011, according to Bloomberg. The move will allow Lam to supplement its etch and single-wafer semiconductor systems with Novellus's thin-film design capabilities to better compete in the consolidating semiconductor industry. Shares of Novellus were surging 24.4% to $43.15 in premarket trading Thursday. Lam Research shares were down 0.6% to $39.25.
FedEx (FDX) beat estimates and said it has signed a deal with Boeing to buy 27 new 767 jets. It is also delaying delivery of 11 Boeing 777s. The company earned $1.57 a share in the fiscal second quarter ended Nov. 30. Analysts surveyed by Thomson Reuters had estimated $1.52 a share. Shares were gaining 3% to $79.60.
VeriFone Systems (PAY), the electronic payments technology company, gave a below-consensus profit outlook for its fiscal first quarter. The company said it expects non-GAAP earnings of 50 cents to 52 cents a share in the three months ending in January on revenue of between $415 million to $420 million. That view is below analysts' expectations of a profit of 53 cents a share in the January quarter on revenue of $408 million. For the whole of fiscal 2012, VeriFone forecast an adjusted profit of $2.53 to $2.60 a share on revenue of $1.9 billion to $1.92 billion. Wall Street's current consensus estimate is for full-year earnings of $2.49 a share on revenue of $1.73 billion. Shares were down 0.5% to $40.33.
Rite Aid (RAD), the drugstore chain, reported a third-quarter loss of 6 cents a share on revenue of $6.3 billion. Analysts, on average, expected the company to post a loss of 11 cents a share on revenue of $6.29 billion. Same-store sales increased 2% over the prior quarter. Rite Aid now expects fiscal 2012 sales between $25.85 billion and $26 billion, compared with the previous guidance of $25.8 billion and $26.1 billion. Same-store sales are expected to range from an increase of 1.15% to an increase of 1.75%, compared with the previous outlook of an increase of 0.75% to an increase of 2%. The fiscal 2012 net loss is now expected to be between 37 cents to 50 cents a share, an improvement from the previous guidance of a loss of 40 cents to 56 cents a share.
Research In Motion (RIMM), the BlackBerry maker, reports third-quarter earnings after the closing bell Thursday. The company has said it expects profit at the "low to mid point" of the $1.20 to $1.40 per share it previously forecast. Analysts expect earnings of $1.20 a share. RIM said it expects third-quarter revenue slightly below its previous forecast of $5.3 billion to $5.6 billion; analysts see revenue of $5.23 billion. Earlier this month, RIM also said it no longer expects to meet its full-year adjusted diluted earnings per share guidance of $5.25 to $6.
Discover Financial Services (DFS), the credit card company, is expected to earn 89 cents a share in the fourth quarter on revenue of $1.8 billion. -- Written by Joseph Woelfel and Andrea Tse
>To contact the writer of this article, click here: Andrea Tse. >To submit a news tip, send an email to: tips@thestreet.com.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV